Moreover, PARPi increases the susceptibility of tumour cells to natural killer (NK) cell mediated apoptosis, encourages pro-inflammatory differentiation of T cells and down-regulation of immune checkpoint receptors such as PD-1. Here, PDCD1 is linked to neoplasm.